abstract |
The present invention relates to at least one novel anti-amyloid antibody, comprising isolated nucleic acids encoding at least one anti-amyloid antibody, amyloid, vectors, host cells, transgenic animals or plants, and manufacturing techniques. and use thereof, including compositions, techniques and therapeutic devices. |